Nasopharyngeal Carcinoma
1 competing product in clinical development for Nasopharyngeal Carcinoma.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nanatinostat + Valganciclovir + Pembrolizumab | Viracta Therapeutics | Phase 1 | Terminated | 25 |